ezetimibe has been researched along with Metabolic Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aihara, K; Akaike, M; Dagvasumberel, M; Hirata, Y; Ishikawa, K; Iwase, T; Koshiba, K; Kusunose, K; Matsumoto, T; Niki, T; Sata, M; Soeki, T; Sumitomo-Ueda, Y; Taketani, Y; Tomita, N; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K; Yoshida, S | 1 |
Davidson, MH | 1 |
1 review(s) available for ezetimibe and Metabolic Diseases
Article | Year |
---|---|
Therapies targeting exogenous cholesterol uptake: new insights and controversies.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; ATP-Binding Cassette Transporters; Azetidines; Bile Acids and Salts; Biological Transport; Cholesterol; Cholesterol, HDL; Drug Discovery; Ezetimibe; Humans; Intestinal Absorption; Metabolic Diseases; Mice; Molecular Targeted Therapy; Sitosterols; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2 | 2011 |
1 other study(ies) available for ezetimibe and Metabolic Diseases
Article | Year |
---|---|
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Anticholesteremic Agents; Azetidines; C-Reactive Protein; Case-Control Studies; Cholesterol, LDL; Deoxyguanosine; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Tumor Necrosis Factor-alpha | 2010 |